ANI PHARMACEUTICALS, INC Business Acquisition, Transaction Costs
ANI PHARMACEUTICALS, INC (ANIP) had Business Acquisition, Transaction Costs of $7.09 million as of 2014-09-30, per its 10-Q filed 2014-11-10.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation
us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts · last filed 2016-02-23
- 2014-09-30: Business Acquisition, Transaction Costs $7.09M.
- 2014-06-30: Business Acquisition, Transaction Costs $7.09M.
- 2014-03-31: Business Acquisition, Transaction Costs $7.09M.
- 2013-12-31: Business Acquisition, Transaction Costs $7.09M.
| Period end | Business Acquisition, Transaction Costs |
|---|---|
| 2014-09-30 | $7.09M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $7.09M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $7.09M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $7.09M 10-K · filed 2016-02-23 |
| 2013-09-30 | $7.09M 10-Q · filed 2013-11-07 |
| 2013-06-30 | $6.59M 10-Q · filed 2013-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |